Accor SA shares are listed on the Euronext Paris stock exchange (ISIN: FR0000120404) and traded in the United States on the OTC market (Code: ACRFY) For more information or to make a reservation, go to accorhotels.group or …
Acorda Therapeutics, Inc. (Nasdaq: ACOR) 33% LOWER; announced that it has …
Acorda Therapeutics Inc. (ACOR) shares dropped 2.5% in premarket trade Monday after the company said it will discontinue its Parkinson's disease drug tozadenant. The company said last Wednesday …
Acorda Therapeutics Inc. (NASDAQ: ACOR) saw its shares drop sharply following an update ... Following the announcement, the stock was down about 37% at $17.75 in early trading indications Wednesday.
Dialing back expectations for toz, the analyst reiterates a Neutral rating on ACOR stock while cutting the price target …
Acorda Therapeutics Inc (ACOR) soared 8.9% or $1.60 to $19.40 after the biopharmaceutical ... agreed to acquire smaller rival Cavium Inc for about $6 billion in a cash-and-stock deal. Under the terms, Cavium investor will receive $40 per …
Before we begin, a quick shot: it seems that Acorda Therapeutics (NASDAQ:ACOR) is recovering a significant chunk of ... I have no business relationship with any …
Acorda Therapeutics, Inc. ACOR reported adjusted earnings of 43 cents per share ... far this year compared with the industry’s 3.3% increase. Including the impact of …